Despite Recent Dip, Alembic Pharmaceuticals Remains a Strong Player in the Market

Jul 30 2024 12:20 PM IST
share
Share Via
Alembic Pharmaceuticals ., a leading player in the pharmaceutical industry, saw a -3.35% decrease in its stock price on July 30, 2024. However, the company's overall trend has been positive and it is currently rated as a 'Buy' by MarketsMojo. Despite underperforming the sector today, the stock is still close to its 52-week high and has consistently outperformed the market in the past month.


Alembic Pharmaceuticals ., a leading player in the pharmaceutical industry, has recently seen a dip in its stock price. On July 30, 2024, the company's stock lost -3.35%, closing at Rs 1211.75. However, this dip should not be a cause for concern for investors as the overall trend for the company has been positive.

According to MarketsMOJO, a leading stock analysis platform, Alembic Pharmaceuticals . is currently rated as a 'Buy'. This is a testament to the company's strong performance and potential for growth in the future.

Despite the recent dip, Alembic Pharmaceuticals . is still close to its 52-week high of Rs 1254.8, with only a 4.72% difference. This shows that the company has been consistently performing well in the market.

In terms of today's performance, Alembic Pharmaceuticals . has underperformed the sector by -3.19%. However, this can be attributed to the overall market conditions and is not a reflection of the company's performance.

It is also worth noting that the stock has fallen after 4 consecutive days of gains, indicating a possible trend reversal. This could be a good opportunity for investors to buy the stock at a lower price.

On the intraday front, Alembic Pharmaceuticals . touched a low of Rs 1197.1, a decrease of -3.23%. However, the stock is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for investors.

In comparison to the overall market performance, Alembic Pharmaceuticals . has seen a -3.42% decrease in its stock price, while the Sensex has only seen a 0.41% increase. However, over the past month, the company has outperformed the Sensex with a 36.32% increase, compared to the Sensex's 3.36% increase.

In conclusion, despite the recent dip in its stock price, Alembic Pharmaceuticals . remains a strong player in the pharmaceutical industry with a positive outlook for the future. Investors should not be deterred by short-term fluctuations and instead focus on the company's overall performance and potential for growth.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News